Literature DB >> 27898335

Genetically edited pigs lacking CD163 show no resistance following infection with the African swine fever virus isolate, Georgia 2007/1.

Luca Popescu1, Natasha N Gaudreault2, Kristen M Whitworth3, Maria V Murgia1, Jerome C Nietfeld1, Alan Mileham4, Melissa Samuel3, Kevin D Wells3, Randall S Prather3, Raymond R R Rowland1.   

Abstract

African swine fever is a highly contagious, often fatal disease of swine for which there is no vaccine or other curative treatment. The macrophage marker, CD163, is a putative receptor for African swine fever virus (ASFV). Pigs possessing a complete knockout of CD163 on macrophages were inoculated with Georgia 2007/1, a genotype 2 isolate. Knockout and wild type pen mates became infected and showed no differences in clinical signs, mortality, pathology or viremia. There was also no difference following in vitro infection of macrophages. The results do not rule out the possibility that other ASFV strains utilize CD163, but demonstrate that CD163 is not necessary for infection with the Georgia 2007/1 isolate. This work rules out a significant role for CD163 in ASFV infection and creates opportunities to focus on alternative receptors and entry mechanisms.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African swine fever; CD163; Receptor; Virus

Mesh:

Substances:

Year:  2016        PMID: 27898335     DOI: 10.1016/j.virol.2016.11.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  ASF Exit Strategy: Providing cumulative evidence of the absence of African swine fever virus circulation in wild boar populations using standard surveillance measures.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Stahl; Antonio Velarde; Christoph Winckler; José Cortiňas Abrahantes; Sofie Dhollander; Corina Ivanciu; Alexandra Papanikolaou; Yves Van der Stede; Sandra Blome; Vittorio Guberti; Federica Loi; Simon More; Edvins Olsevskis; Hans Hermann Thulke; Arvo Viltrop
Journal:  EFSA J       Date:  2021-03-03

Review 2.  Improvements in pig agriculture through gene editing.

Authors:  Kristin M Whitworth; Jonathan A Green; Bethany K Redel; Rodney D Geisert; Kiho Lee; Bhanu P Telugu; Kevin D Wells; Randall S Prather
Journal:  CABI Agric Biosci       Date:  2022-06-21

Review 3.  Cell Lines for the Development of African Swine Fever Virus Vaccine Candidates: An Update.

Authors:  Dionigia Meloni; Giulia Franzoni; Annalisa Oggiano
Journal:  Vaccines (Basel)       Date:  2022-04-29

4.  Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production.

Authors:  Elena G Sánchez; Elena Riera; Marisa Nogal; Carmina Gallardo; Paloma Fernández; Raquel Bello-Morales; José Antonio López-Guerrero; Carol G Chitko-McKown; Jürgen A Richt; Yolanda Revilla
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 5.  African Swine Fever Virus: A Review.

Authors:  Inmaculada Galindo; Covadonga Alonso
Journal:  Viruses       Date:  2017-05-10       Impact factor: 5.048

6.  Efficient inhibition of African swine fever virus replication by CRISPR/Cas9 targeting of the viral p30 gene (CP204L).

Authors:  Alexandra Hübner; Bjoern Petersen; Günther M Keil; Heiner Niemann; Thomas C Mettenleiter; Walter Fuchs
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

7.  A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs Against Fatal Disease.

Authors:  Lynnette C Goatley; Ana Luisa Reis; Raquel Portugal; Hannah Goldswain; Gareth L Shimmon; Zoe Hargreaves; Chak-Sum Ho; María Montoya; Pedro J Sánchez-Cordón; Geraldine Taylor; Linda K Dixon; Christopher L Netherton
Journal:  Vaccines (Basel)       Date:  2020-05-18

8.  Infectious Dose of African Swine Fever Virus When Consumed Naturally in Liquid or Feed.

Authors:  Megan C Niederwerder; Ana M M Stoian; Raymond R R Rowland; Steve S Dritz; Vlad Petrovan; Laura A Constance; Jordan T Gebhardt; Matthew Olcha; Cassandra K Jones; Jason C Woodworth; Ying Fang; Jia Liang; Trevor J Hefley
Journal:  Emerg Infect Dis       Date:  2019-05-17       Impact factor: 6.883

Review 9.  Mechanisms of Entry and Endosomal Pathway of African Swine Fever Virus.

Authors:  Elena G. Sánchez; Daniel Pérez-Núñez; Yolanda Revilla
Journal:  Vaccines (Basel)       Date:  2017-11-08

10.  Gene expression analysis of whole blood RNA from pigs infected with low and high pathogenic African swine fever viruses.

Authors:  Crystal Jaing; Raymond R R Rowland; Jonathan E Allen; Andrea Certoma; James B Thissen; John Bingham; Brenton Rowe; John R White; James W Wynne; Dayna Johnson; Natasha N Gaudreault; David T Williams
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.